Amedisys (AMED)
(Delayed Data from NSDQ)
$97.21 USD
+0.06 (0.06%)
Updated Sep 19, 2024 04:00 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Amedisys, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.94 | 117.70 | 210.17 | 185.18 | 127.91 |
Depreciation/Amortization & Depletion | 58.83 | 71.96 | 72.18 | 68.81 | 55.21 |
Net Change from Assets/Liabilities | -63.21 | -105.04 | -131.02 | 26.22 | -31.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 152.50 | 48.67 | 37.56 | 8.74 | 50.24 |
Net Cash From Operating Activities | 137.19 | 133.28 | 188.89 | 288.95 | 202.00 |
Property & Equipment | -5.48 | -6.10 | -6.02 | -5.15 | -7.28 |
Acquisition/ Disposition of Subsidiaries | 47.44 | -71.95 | -269.97 | -298.96 | -345.46 |
Investments | -6.94 | -16.69 | -5.62 | 17.00 | -0.21 |
Other Investing Activities | 0.05 | 0.25 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 35.06 | -94.49 | -281.61 | -287.11 | -352.95 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -3.83 | -19.18 | -110.75 | -44.61 | -2.76 |
Issuance (Repayment) of Debt | -76.01 | -13.30 | 281.17 | -29.25 | 231.88 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -51.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.68 | 2.04 | -64.29 | 58.88 | -1.91 |
Net Cash from Financing Activities | -87.52 | -30.43 | 55.13 | -14.98 | 227.21 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 84.73 | 8.36 | -37.59 | -13.13 | 76.26 |
Cash at Beginning of Period | 54.13 | 45.77 | 83.36 | 96.49 | 20.23 |
Cash at End of Period | 138.86 | 54.13 | 45.77 | 83.36 | 96.49 |
Diluted Net EPS | -0.30 | 3.63 | 6.34 | 5.52 | 3.84 |
Fiscal Year End for Amedisys, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 47.17 | 14.59 | -10.94 | -29.96 | -55.57 |
Depreciation/Amortization & Depletion | 30.09 | 14.95 | 58.83 | 44.13 | 29.36 |
Net Change from Assets/Liabilities | -52.53 | -45.83 | -63.21 | -75.81 | -10.73 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 21.04 | 9.74 | 152.50 | 138.52 | 123.67 |
Net Cash From Operating Activities | 45.76 | -6.54 | 137.19 | 76.88 | 86.72 |
Property & Equipment | -4.06 | -2.65 | -5.48 | -3.63 | -2.64 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 47.44 | 47.44 | 47.44 |
Investments | -0.61 | -0.42 | -6.94 | -6.73 | -6.67 |
Other Investing Activities | 0.02 | 0.00 | 0.05 | 0.03 | 0.03 |
Net Cash from Investing Activities | -4.64 | -3.07 | 35.06 | 37.10 | 38.15 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -4.20 | -0.62 | -3.83 | -1.71 | -1.66 |
Issuance (Repayment) of Debt | -18.38 | -8.94 | -76.01 | -67.11 | -60.99 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.05 | 1.01 | -7.68 | -5.27 | -5.19 |
Net Cash from Financing Activities | -22.63 | -8.55 | -87.52 | -74.10 | -67.84 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 18.50 | -18.16 | 84.73 | 39.88 | 57.03 |
Cash at Beginning of Period | 138.86 | 138.86 | 54.13 | 54.13 | 54.13 |
Cash at End of Period | 157.36 | 120.70 | 138.86 | 94.02 | 111.16 |
Diluted Net EPS | 0.98 | 0.44 | 0.60 | 0.79 | -2.46 |